Caplin Point up 20% on USFDA approval for Verapamil Hydrochloride injection

Shares of Caplin Point Laboratories were locked in the 20 per cent upper circuit at Rs 245 on the BSE on Thursday after the company’s arm Caplin Steriles received final approval from the US drug regulator for Verapamil Hydrochloride injection.

Verapamil Hydrochloride is a calcium channel blocker used in the treatment of cardiac conditions such as high blood pressure, arrhythmias and angina.

Till 12:38 pm, a combined 163,654 shares have changed hands on the NSE and BSE, and there were pending buy orders for 18,735 shares, exchange data shows.

"The company’s wholly owned subsidiary, Caplin Steriles, has been granted final approval by the